Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Stagg Robert | See Remarks | 4 | $0 | $16.3K | 2019-04-23 |
| Li Yvonne | See Remarks | 5 | $0 | $18.1K | 2019-04-23 |
| Hager Alicia J. | VP & General Counsel | 44 | $0 | $485.2K | 2019-04-23 |
| Lewicki John A. | President and CEO | 84 | $0 | $1.93M | 2019-04-23 |
| PAKIANATHAN DEEPIKA | Director | 19 | $8.02M | $0 | 2019-04-23 |
| KARSEN PERRY A | Director | 8 | $34.6K | $0 | 2019-04-23 |
| ROOT JONATHAN D | Director, 10% Owner | 64 | $2.70M | $699.3K | 2019-04-23 |
| LASERSOHN JACK W | Director | 49 | $717.0K | $0 | 2019-04-23 |
| Gurney Austin | See remarks | 45 | $0 | $1.78M | 2018-12-24 |
| Winningham Rick E | Director | 4 | $0 | $0 | 2018-06-22 |
| Pollard-Knight Denise | Director | 22 | $1.00M | $4.07M | 2018-06-22 |
| WYZGA MICHAEL S | Director | 6 | $0 | $0 | 2018-06-22 |
| Patel Sunil | See Remarks | 24 | $0 | $605.3K | 2018-01-04 |
| HASTINGS PAUL J | President & CEO | 40 | $0 | $1.21M | 2017-10-10 |
| Lasky Laurence | Director | 8 | $0 | $0 | 2017-06-01 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | 48 | $0 | $1.18M | 2017-04-23 |
| Dupont Jakob | SVP & Chief Medical Officer | 51 | $0 | $858.5K | 2016-10-09 |
| Gould Terry P | Director | 62 | $0 | $0 | 2016-06-22 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 38 | $2.70M | $651.8K | 2014-08-08 |
| USVP ENTREPRENEUR PARTNERS VIII B L P | 10% Owner | 4 | $0 | $320.7K | 2014-06-10 |
| USVP ENTREPRENEUR PARTNERS VIII A L P | 10% Owner | 11 | $0 | $1.02M | 2014-05-12 |
| Broderick James W. | Director | 7 | $1.20M | $0 | 2013-07-23 |
| Woody James N. | Director, 10% Owner | 31 | $1.50M | $0 | 2013-07-23 |
| Waddill William D. | SVP & Chief Financial Officer | 3 | $0 | $0 | 2013-07-23 |
| LVP Life Science Ventures II, L.P. | 10% Owner | 29 | $1.50M | $0 | 2013-07-23 |
| FEDERMAN IRWIN | 10% Owner | 28 | $2.70M | $0 | 2013-07-23 |
| VERTICAL GROUP LP | 10% Owner | 12 | $0 | $0 | 2013-07-23 |
| MORGENTHALER PARTNERS VII LP | 10% Owner | 7 | $1.20M | $0 | 2013-07-23 |
| GLAXOSMITHKLINE PLC | 10% Owner | 4 | $0 | $0 | 2013-07-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| KARSEN PERRY A | Director | U Tender | 2019-04-23 | 2019-04-23 | 80,500 | — | $0 | 0 | SEC↗ |
| Stagg Robert | See Remarks | U Tender | 2019-04-23 | 2019-04-23 | 28,917 | — | $0 | 0 | SEC↗ |
| Li Yvonne | See Remarks | U Tender | 2019-04-23 | 2019-04-23 | 65,895 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | U Tender | 2019-04-23 | 2019-04-23 | 1,991,602 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | U Tender | 2019-04-23 | 2019-04-23 | 18,940 | — | $0 | 0 | SEC↗ |
| Lewicki John A. | President and CEO | U Tender | 2019-04-23 | 2019-04-23 | 142,534 | — | $0 | 0 | SEC↗ |
| LASERSOHN JACK W | Director | U Tender | 2019-04-23 | 2019-04-23 | 185,709 | — | $0 | 0 | SEC↗ |
| LASERSOHN JACK W | Director | U Tender | 2019-04-23 | 2019-04-23 | 380,299 | — | $0 | 0 | SEC↗ |
| LASERSOHN JACK W | Director | U Tender | 2019-04-23 | 2019-04-23 | 1,119,905 | — | $0 | 0 | SEC↗ |
| ROOT JONATHAN D | Director | U Tender | 2019-04-23 | 2019-04-23 | 121,020 | — | $0 | 0 | SEC↗ |
| Hager Alicia J. | SVP and General Counsel | U Tender | 2019-04-23 | 2019-04-23 | 39,488 | — | $0 | 0 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2018-12-24 | 2018-12-26 | 11,117 | $0.60 | $6.7K | 66,807 | SEC↗ |
| Lewicki John A. | President & CEO | S Sale | 2018-10-10 | 2018-10-11 | 1,156 | $2.01 | $2.3K | 55,966 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2018-10-10 | 2018-10-11 | 1,156 | $2.02 | $2.3K | 51,754 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2018-10-10 | 2018-10-11 | 1,156 | $2.01 | $2.3K | 77,924 | SEC↗ |
| Li Yvonne | See Remarks | S Sale | 2018-10-10 | 2018-10-11 | 927 | $2.02 | $1.9K | 59,734 | SEC↗ |
| Stagg Robert | SVP, Clinical R&D | S Sale | 2018-10-10 | 2018-10-11 | 927 | $2.01 | $1.9K | 40,670 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2018-10-09 | 2018-10-10 | 1,686 | $2.13 | $3.6K | 52,910 | SEC↗ |
| Lewicki John A. | President & CEO | S Sale | 2018-10-09 | 2018-10-10 | 2,296 | $2.13 | $4.9K | 57,122 | SEC↗ |
| Stagg Robert | SVP, Clinical R&D | S Sale | 2018-10-09 | 2018-10-10 | 1,686 | $2.13 | $3.6K | 41,597 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2018-10-09 | 2018-10-10 | 1,686 | $2.13 | $3.6K | 79,080 | SEC↗ |
| Li Yvonne | See Remarks | S Sale | 2018-10-09 | 2018-10-10 | 1,229 | $2.13 | $2.6K | 60,661 | SEC↗ |
| Winningham Rick E | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ROOT JONATHAN D | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LASERSOHN JACK W | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KARSEN PERRY A | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Pollard-Knight Denise | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2018-04-24 | 2018-04-26 | 4,051 | $2.68 | $10.9K | 54,596 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2018-04-24 | 2018-04-26 | 4,051 | $2.68 | $10.9K | 76,766 | SEC↗ |
| Lewicki John A. | President & CEO | S Sale | 2018-04-24 | 2018-04-26 | 4,557 | $2.68 | $12.2K | 55,418 | SEC↗ |
| Stagg Robert | SVP, Clinical R&D | S Sale | 2018-04-24 | 2018-04-26 | 4,051 | $2.68 | $10.9K | 43,283 | SEC↗ |
| Li Yvonne | See Remarks | S Sale | 2018-04-24 | 2018-04-26 | 5,062 | $2.68 | $13.6K | 59,890 | SEC↗ |
| Li Yvonne | See Remarks | A Award deriv | 2018-03-18 | 2018-03-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Lewicki John A. | President & CEO | A Award deriv | 2018-03-16 | 2018-03-19 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KARSEN PERRY A | Director | A Award deriv | 2018-02-26 | 2018-02-28 | 120,000 | — | $0 | 120,000 | SEC↗ |
| KARSEN PERRY A | Director | A Award | 2018-02-26 | 2018-02-28 | 70,500 | — | $0 | 80,500 | SEC↗ |
| Lewicki John A. | President | A Award deriv | 2018-02-21 | 2018-02-23 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | A Award deriv | 2018-01-04 | 2018-01-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Gurney Austin | See Remarks | A Award deriv | 2018-01-04 | 2018-01-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award deriv | 2018-01-04 | 2018-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Patel Sunil | See Remarks | A Award deriv | 2018-01-04 | 2018-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.26 | $196 | 59,849 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 58,647 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.27 | $196 | 82,019 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 80,817 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.26 | $196 | 71,614 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 70,412 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2017-10-10 | 2017-10-12 | 1,346 | $4.24 | $5.7K | 76,188 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2017-10-10 | 2017-10-12 | 52 | $4.26 | $222 | 77,534 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.27 | $196 | 69,538 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 68,336 | SEC↗ |
| Gurney Austin | See Remarks | A Award deriv | 2017-10-07 | 2017-10-10 | 36,666 | — | $0 | 36,666 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | A Award deriv | 2017-10-07 | 2017-10-10 | 36,666 | — | $0 | 36,666 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award deriv | 2017-10-07 | 2017-10-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Patel Sunil | See Remarks | A Award deriv | 2017-10-07 | 2017-10-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Gurney Austin | See Remarks | A Award | 2017-10-07 | 2017-10-10 | 18,334 | — | $0 | 82,065 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | A Award | 2017-10-07 | 2017-10-10 | 18,334 | — | $0 | 59,895 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award | 2017-10-07 | 2017-10-10 | 25,000 | — | $0 | 71,660 | SEC↗ |
| Patel Sunil | See Remarks | A Award | 2017-10-07 | 2017-10-10 | 25,000 | — | $0 | 69,584 | SEC↗ |
| KARSEN PERRY A | Director | P Buy | 2017-06-05 | 2017-06-07 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Winningham Rick E | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ROOT JONATHAN D | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Pollard-Knight Denise | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lasky Laurence | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LASERSOHN JACK W | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KARSEN PERRY A | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-26 | 2017-05-26 | 6,358 | $3.70 | $23.5K | 0 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-26 | 2017-05-26 | 3,222 | $3.70 | $11.9K | 0 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2017-05-25 | 2017-05-26 | 34,614 | $3.37 | $116.6K | 185,709 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-24 | 2017-05-26 | 2,853 | $3.72 | $10.6K | 6,358 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-24 | 2017-05-26 | 1,447 | $3.72 | $5.4K | 3,222 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2017-05-23 | 2017-05-25 | 20,000 | $3.55 | $71.0K | 151,095 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-19 | 2017-05-22 | 4,968 | $3.70 | $18.4K | 9,211 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-19 | 2017-05-22 | 2,519 | $3.70 | $9.3K | 4,669 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-16 | 2017-05-18 | 4,579 | $3.58 | $16.4K | 14,179 | SEC↗ |
| ROOT JONATHAN D | Director | S Sale | 2017-05-16 | 2017-05-18 | 2,321 | $3.58 | $8.3K | 7,188 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2017-05-16 | 2017-05-18 | 23,507 | $3.49 | $82.0K | 131,095 | SEC↗ |
| ROOT JONATHAN D | Director | J Other | 2017-05-11 | 2017-05-15 | 55,929 | — | $0 | 121,020 | SEC↗ |
| ROOT JONATHAN D | Director | J Other | 2017-05-11 | 2017-05-15 | 1,990,783 | — | $0 | 0 | SEC↗ |
| ROOT JONATHAN D | Director | J Other | 2017-05-11 | 2017-05-15 | 19,215 | — | $0 | 0 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | A Award deriv | 2017-04-24 | 2017-04-25 | 135,000 | — | $0 | 135,000 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | A Award | 2017-04-24 | 2017-04-25 | 45,000 | — | $0 | 77,586 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Gurney Austin | See Remarks | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award deriv | 2017-04-23 | 2017-04-25 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Patel Sunil | See Remarks | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 41,561 | SEC↗ |
| Gurney Austin | See Remarks | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 63,301 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award | 2017-04-23 | 2017-04-25 | 22,500 | — | $0 | 45,437 | SEC↗ |
| Patel Sunil | See Remarks | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 44,584 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 77,225 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2017-04-04 | 2017-04-05 | 48 | $8.87 | $426 | 39,011 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2017-04-04 | 2017-04-05 | 6,425 | $9.06 | $58.2K | 32,586 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2017-04-04 | 2017-04-05 | 32 | $8.87 | $284 | 25,845 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2017-04-04 | 2017-04-05 | 4,284 | $9.06 | $38.8K | 21,561 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 57,225 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 62,936 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 24,584 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 30,295 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 49,012 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 43,301 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 28,648 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 22,937 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | M Exercise deriv | 2017-03-15 | 2017-03-17 | 6,652 | — | $0 | 0 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | M Exercise | 2017-03-15 | 2017-03-17 | 6,652 | $3.42 | $22.7K | 32,529 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | S Sale | 2017-03-15 | 2017-03-17 | 6,652 | $10.00 | $66.5K | 25,877 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2017-01-10 | 2017-01-11 | 108,810 | — | $0 | 380,299 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2017-01-10 | 2017-01-11 | 305,122 | — | $0 | 1,119,905 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2017-01-10 | 2017-01-11 | 30,501 | — | $0 | 107,588 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | M Exercise deriv | 2017-01-06 | 2017-01-09 | 21,369 | — | $0 | 0 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | M Exercise | 2017-01-06 | 2017-01-09 | 21,369 | $1.43 | $30.6K | 58,692 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2017-01-06 | 2017-01-09 | 21,369 | $8.52 | $182.1K | 37,323 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | M Exercise deriv | 2017-01-05 | 2017-01-09 | 21,369 | — | $0 | 21,369 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | M Exercise | 2017-01-05 | 2017-01-09 | 21,369 | $1.43 | $30.6K | 58,692 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2017-01-05 | 2017-01-09 | 21,369 | $8.17 | $174.6K | 37,323 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | M Exercise deriv | 2017-01-03 | 2017-01-05 | 12,763 | — | $0 | 0 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | A Award deriv | 2017-01-03 | 2017-01-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Gurney Austin | See Remarks | A Award deriv | 2017-01-03 | 2017-01-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Patel Sunil | See Remarks | A Award deriv | 2017-01-03 | 2017-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | A Award deriv | 2017-01-03 | 2017-01-05 | 176,000 | — | $0 | 176,000 | SEC↗ |
| Hager Alicia J. | SVP & General Counsel | A Award deriv | 2017-01-03 | 2017-01-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award deriv | 2017-01-03 | 2017-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | M Exercise deriv | 2017-01-03 | 2017-01-05 | 9,175 | — | $0 | 0 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | M Exercise | 2017-01-03 | 2017-01-05 | 12,763 | $1.43 | $18.3K | 73,742 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | S Sale | 2017-01-03 | 2017-01-05 | 12,763 | $7.64 | $97.5K | 60,979 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | S Sale | 2017-01-03 | 2017-01-05 | 9,175 | $7.63 | $70.0K | 31,636 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | M Exercise | 2017-01-03 | 2017-01-05 | 9,175 | $1.43 | $13.1K | 40,811 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | M Exercise deriv | 2016-11-16 | 2016-11-18 | 12,500 | — | $0 | 12,763 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | M Exercise | 2016-11-16 | 2016-11-18 | 12,500 | $1.43 | $17.9K | 73,479 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | S Sale | 2016-11-16 | 2016-11-18 | 12,500 | $9.89 | $123.6K | 60,979 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2016-10-10 | 2016-10-12 | 822 | — | $0 | 489,109 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2016-10-10 | 2016-10-12 | 3,287 | — | $0 | 1,425,027 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 25,877 | SEC↗ |
| Patel Sunil | See Remarks | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 30,338 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 34,440 | SEC↗ |
| Gurney Austin | SVP & Co-CSO | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 47,055 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | A Award | 2016-10-09 | 2016-10-11 | 14,000 | — | $0 | 37,323 | SEC↗ |
| Hoey Timothy | SVP & Co-CSO | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 60,979 | SEC↗ |
| Lewicki John A. | EVP, Research & Development | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 31,636 | SEC↗ |
| Gould Terry P | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KARSEN PERRY A | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LASERSOHN JACK W | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lasky Laurence | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Pollard-Knight Denise | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ROOT JONATHAN D | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Winningham Rick E | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2016-03-17 | 2016-03-21 | 108,840 | — | $0 | 488,287 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2016-03-17 | 2016-03-21 | 305,122 | — | $0 | 1,421,740 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2016-03-17 | 2016-03-21 | 30,527 | — | $0 | 77,087 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2016-01-11 | 2016-01-12 | 2,500 | — | $0 | 138,937 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2016-01-11 | 2016-01-12 | 2,500 | $4.56 | $11.4K | 23,142 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2016-01-11 | 2016-01-12 | 2,500 | $20.01 | $50.0K | 20,642 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 17,838 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 17,838 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 13,377 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 47,181 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 33,257 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 20,642 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.56 | $1.5K | 17,839 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 17,908 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.65 | $1.5K | 17,839 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 17,908 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2016-01-06 | 2016-01-08 | 1,570 | $22.30 | $35.0K | 13,430 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2016-01-06 | 2016-01-08 | 52 | $21.54 | $1.1K | 13,378 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2016-01-06 | 2016-01-08 | 77 | $21.54 | $1.7K | 22,025 | SEC↗ |
| HASTINGS PAUL J | Chairman & CEO | S Sale | 2016-01-06 | 2016-01-08 | 2,335 | $22.30 | $52.1K | 22,102 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.56 | $1.5K | 47,182 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 47,251 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 33,327 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.54 | $1.5K | 33,258 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 20,712 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.54 | $1.5K | 20,643 | SEC↗ |
| KARSEN PERRY A | Director | A Award deriv | 2016-01-04 | 2016-01-06 | 30,189 | — | $0 | 30,189 | SEC↗ |
| HASTINGS PAUL J | Chief Executive Officer | A Award deriv | 2015-12-28 | 2016-03-25 | 170,000 | — | $0 | 170,000 | SEC↗ |
| HASTINGS PAUL J | Chief Executive Officer | A Award deriv | 2015-12-27 | 2015-12-29 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | A Award deriv | 2015-12-27 | 2015-12-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | A Award deriv | 2015-12-27 | 2015-12-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Patel Sunil | SVP & Chief Financial Office | A Award deriv | 2015-12-27 | 2015-12-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | A Award deriv | 2015-12-27 | 2015-12-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Gurney Austin | See remarks | A Award deriv | 2015-12-27 | 2015-12-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | A Award deriv | 2015-12-27 | 2015-12-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-12-10 | 2015-12-14 | 2,500 | — | $0 | 141,437 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-12-10 | 2015-12-14 | 2,500 | $4.56 | $11.4K | 25,304 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-12-10 | 2015-12-14 | 2,500 | $20.49 | $51.2K | 22,804 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2015-11-30 | 2015-12-02 | 57,583 | — | $0 | 1,726,862 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2015-11-30 | 2015-12-02 | 13,699 | — | $0 | 597,127 | SEC↗ |
| ROOT JONATHAN D | Director | J Other | 2015-11-30 | 2015-12-02 | 429 | — | $0 | 65,091 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 2,939 | — | $0 | 12,046 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 22,125 | — | $0 | 90,349 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 14,695 | — | $0 | 59,567 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 39,017 | — | $0 | 125,060 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 7,026 | — | $0 | 28,691 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 9,205 | — | $0 | 37,591 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 24,631 | — | $0 | 82,395 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 2,431 | — | $0 | 7,294 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 782 | — | $0 | 2,346 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 1,166 | — | $0 | 3,498 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 19,666 | — | $0 | 59,000 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 14,118 | — | $0 | 42,355 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-11-30 | 2015-12-02 | 18,277 | — | $0 | 54,833 | SEC↗ |
| Lasky Laurence | Director | J Other | 2015-11-30 | 2015-12-02 | 7,433 | — | $0 | 10,332 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise deriv | 2015-11-27 | 2015-12-01 | 1,800 | — | $0 | 6,652 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise | 2015-11-27 | 2015-12-01 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-11-27 | 2015-12-01 | 1,800 | $23.14 | $41.7K | 15,000 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-11-10 | 2015-11-12 | 2,500 | — | $0 | 143,937 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-11-10 | 2015-11-12 | 2,500 | $21.17 | $52.9K | 22,804 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-11-10 | 2015-11-12 | 2,500 | $4.56 | $11.4K | 25,304 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise deriv | 2015-10-27 | 2015-10-29 | 5,400 | — | $0 | 8,452 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-10-27 | 2015-10-29 | 5,400 | $21.00 | $113.4K | 15,000 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise | 2015-10-27 | 2015-10-29 | 5,400 | $3.42 | $18.5K | 20,400 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-10-26 | 2015-10-27 | 5,000 | — | $0 | 146,437 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-10-26 | 2015-10-27 | 5,000 | $20.00 | $100.0K | 22,804 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-10-26 | 2015-10-27 | 5,000 | $4.56 | $22.8K | 27,804 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-10-26 | 2015-10-27 | 14,000 | $20.00 | $280.0K | 35,419 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2015-09-30 | 2015-10-01 | 9,120 | $16.26 | $148.3K | 46,560 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2015-09-30 | 2015-10-01 | 2,090 | $14.94 | $31.2K | 37,440 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2015-09-29 | 2015-09-30 | 3,140 | $14.15 | $44.4K | 35,350 | SEC↗ |
| LASERSOHN JACK W | Director | P Buy | 2015-09-28 | 2015-09-30 | 10,000 | $14.74 | $147.4K | 32,210 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-08-10 | 2015-08-12 | 2,500 | — | $0 | 151,437 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-08-10 | 2015-08-12 | 2,500 | $4.56 | $11.4K | 24,877 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-08-10 | 2015-08-12 | 2,500 | $22.25 | $55.6K | 22,377 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-07-30 | 2015-07-31 | 5,901 | $21.01 | $124.0K | 50,518 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-07-30 | 2015-07-31 | 1,099 | $21.47 | $23.6K | 49,419 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-07-29 | 2015-07-31 | 7,000 | $20.68 | $144.8K | 56,419 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise deriv | 2015-07-28 | 2015-07-29 | 1,800 | — | $0 | 13,852 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise | 2015-07-28 | 2015-07-29 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-07-28 | 2015-07-29 | 1,800 | $21.00 | $37.8K | 15,000 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-07-10 | 2015-07-13 | 2,500 | — | $0 | 153,937 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-07-10 | 2015-07-13 | 2,500 | $20.13 | $50.3K | 22,377 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-07-10 | 2015-07-13 | 2,500 | $4.56 | $11.4K | 24,877 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-07-06 | 2015-07-07 | 2,500 | — | $0 | 156,437 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-07-06 | 2015-07-07 | 2,500 | $21.22 | $53.0K | 22,377 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-07-06 | 2015-07-07 | 2,500 | $4.56 | $11.4K | 24,877 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise deriv | 2015-06-29 | 2015-06-30 | 1,800 | — | $0 | 15,652 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise | 2015-06-29 | 2015-06-30 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-06-29 | 2015-06-30 | 1,800 | $22.67 | $40.8K | 15,000 | SEC↗ |
| Winningham Rick E | Director | A Award deriv | 2015-06-24 | 2015-06-26 | 30,000 | — | $0 | 0 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | M Exercise deriv | 2015-06-22 | 2015-06-24 | 5,000 | — | $0 | 25,263 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | S Sale | 2015-06-22 | 2015-06-24 | 5,000 | $26.07 | $130.3K | 49,343 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | M Exercise | 2015-06-22 | 2015-06-24 | 5,000 | $1.43 | $7.2K | 54,343 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ROOT JONATHAN D | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LASERSOHN JACK W | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lasky Laurence | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Gould Terry P | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Pollard-Knight Denise | Director | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise deriv | 2015-06-16 | 2015-06-17 | 2,898 | — | $0 | 134,423 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise deriv | 2015-06-16 | 2015-06-17 | 5,602 | — | $0 | 9,175 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise | 2015-06-16 | 2015-06-17 | 5,602 | $1.43 | $8.0K | 25,602 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise | 2015-06-16 | 2015-06-17 | 2,898 | $3.42 | $9.9K | 28,500 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2015-06-16 | 2015-06-17 | 8,500 | $25.22 | $214.4K | 20,000 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise deriv | 2015-06-15 | 2015-06-17 | 8,500 | — | $0 | 14,777 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2015-06-15 | 2015-06-17 | 8,500 | $24.92 | $211.8K | 20,000 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise | 2015-06-15 | 2015-06-17 | 8,500 | $1.43 | $12.2K | 28,500 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise deriv | 2015-05-27 | 2015-05-28 | 1,800 | — | $0 | 17,452 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise | 2015-05-27 | 2015-05-28 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-05-27 | 2015-05-28 | 1,800 | $23.07 | $41.5K | 15,000 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-05-18 | 2015-05-20 | 3,900 | $22.46 | $87.6K | 63,519 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-05-18 | 2015-05-20 | 100 | $23.06 | $2.3K | 63,419 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | M Exercise deriv | 2015-04-27 | 2015-04-29 | 5,000 | — | $0 | 30,263 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise deriv | 2015-04-27 | 2015-04-29 | 1,800 | — | $0 | 19,252 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | S Sale | 2015-04-27 | 2015-04-29 | 3,537 | $25.12 | $88.8K | 52,693 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | S Sale | 2015-04-27 | 2015-04-29 | 3,350 | $26.20 | $87.8K | 49,343 | SEC↗ |
| Hoey Timothy | SVP, Cancer Biology | M Exercise | 2015-04-27 | 2015-04-29 | 5,000 | $1.43 | $7.2K | 56,230 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | M Exercise | 2015-04-27 | 2015-04-29 | 1,800 | $3.42 | $6.2K | 16,800 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-04-27 | 2015-04-29 | 855 | $26.19 | $22.4K | 15,000 | SEC↗ |
| Hager Alicia J. | VP & General Counsel | S Sale | 2015-04-27 | 2015-04-29 | 945 | $25.16 | $23.8K | 15,855 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2015-04-20 | 2015-04-22 | 960 | — | $0 | 651,713 | SEC↗ |
| LASERSOHN JACK W | Director | J Other | 2015-04-20 | 2015-04-22 | 3,840 | — | $0 | 1,669,279 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-04-17 | 2015-04-20 | 150 | $26.52 | $4.0K | 67,419 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-04-17 | 2015-04-20 | 3,850 | $25.47 | $98.1K | 67,569 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-04-10 | 2015-04-14 | 1,500 | — | $0 | 158,937 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-04-10 | 2015-04-14 | 1,500 | $26.51 | $39.8K | 22,377 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-04-10 | 2015-04-14 | 1,500 | $4.56 | $6.8K | 23,877 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise deriv | 2015-04-02 | 2015-04-03 | 8,500 | — | $0 | 23,277 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise | 2015-04-02 | 2015-04-03 | 8,500 | $1.43 | $12.2K | 29,785 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2015-04-02 | 2015-04-03 | 1,560 | $25.70 | $40.1K | 21,285 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2015-04-02 | 2015-04-03 | 6,940 | $25.29 | $175.5K | 22,845 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise deriv | 2015-04-01 | 2015-04-03 | 8,500 | — | $0 | 31,777 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | M Exercise | 2015-04-01 | 2015-04-03 | 8,500 | $1.43 | $12.2K | 29,785 | SEC↗ |
| Lewicki John A. | EVP & Chief Scientific Offic | S Sale | 2015-04-01 | 2015-04-03 | 8,500 | $25.19 | $214.1K | 21,285 | SEC↗ |
| Patel Sunil | See Remarks | M Exercise deriv | 2015-03-20 | 2015-03-23 | 14,665 | — | $0 | 101,595 | SEC↗ |
| Patel Sunil | See Remarks | M Exercise | 2015-03-20 | 2015-03-23 | 14,665 | $3.42 | $50.2K | 34,665 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2015-03-20 | 2015-03-23 | 14,665 | $27.86 | $408.6K | 20,000 | SEC↗ |
| Patel Sunil | See Remarks | M Exercise deriv | 2015-03-19 | 2015-03-23 | 3,335 | — | $0 | 116,260 | SEC↗ |
| Patel Sunil | See Remarks | M Exercise | 2015-03-19 | 2015-03-23 | 3,335 | $3.42 | $11.4K | 23,335 | SEC↗ |
| Patel Sunil | See Remarks | S Sale | 2015-03-19 | 2015-03-23 | 3,335 | $27.34 | $91.2K | 20,000 | SEC↗ |
| Gurney Austin | See Remarks | S Sale | 2015-03-17 | 2015-03-19 | 4,000 | $27.37 | $109.5K | 71,419 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise deriv | 2015-03-10 | 2015-03-12 | 1,500 | — | $0 | 160,437 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | M Exercise | 2015-03-10 | 2015-03-12 | 1,500 | $4.56 | $6.8K | 23,120 | SEC↗ |
| Dupont Jakob | SVP & Chief Medical Officer | S Sale | 2015-03-10 | 2015-03-12 | 1,500 | $27.17 | $40.8K | 21,620 | SEC↗ |
| Gould Terry P | Director | J Other | 2015-02-24 | 2015-02-26 | 26,762 | — | $0 | 68,224 | SEC↗ |